Artículos por temáticas

Relationship between Nutritional Status and the Severity of Huntington’s Disease. A Spanish Multicenter Dietary Intake Study.

Cubo E, Rivadeneyra J, Armesto D, Mariscal N, Martinez A, Camara RJ; Spanish members of the European Huntington Disease Network..

J Huntingtons Dis. 2015;4(1):78-85.

Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.

Lee JH, Tecedor L, Chen YH, Monteys AM, Sowada MJ, Thompson LM, Davidson BL.

Neuron. 2015 Jan 21;85(2):303-15. doi: 10.1016/j.neuron.2014.12.019.

Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease.

Berggren KL, Chen J, Fox J, Miller J, Dodds L, Dugas B, Vargas L, Lothian A, McAllum E, Volitakis I, Roberts B, Bush AI, Fox JH.

Redox Biol. 2015;4:363-74. doi: 10.1016/j.redox.2015.02.002.

Large Subdural Hematoma in Advanced Huntington's Disease.

Miyagawa T, Tsuji S, Iwata A.

Intern Med. 2015;54(11):1461. doi: 10.2169/internalmedicine.54.4159. No abstract available.

The Potential Regulatory Mechanisms of miR-196a in Huntington's Disease through Bioinformatic Analyses.

Fu MH, Li CL, Lin HL, Tsai SJ, Lai YY, Chang YF, Cheng PH, Chen CM, Yang SH.

PLoS One. 2015 Sep 16;10(9):e0137637. doi: 10.1371/journal.pone.0137637.

Globus pallidus interna deep brain stimulation for chorea-acanthocytosis.

Lee JH, Cho WH, Cha SH, Kang DW.

J Korean Neurosurg Soc. 2015 Feb;57(2):143-6. doi: 10.3340/jkns.2015.57.2.143.

Coexistence of Gait Disturbances and Chorea in Experimental Huntington's Disease.

Casaca-Carreira J, Temel Y, van Zelst M, Jahanshahi A.

Behav Neurol. 2015;2015:970204. doi: 10.1155/2015/970204.

Antidopaminergic Medication is Associated with More Rapidly Progressive Huntington's Disease.

Tedroff J, Waters S, Barker RA, Roos R, Squitieri F; EHDN Registry Study Group..

J Huntingtons Dis. 2015;4(2):131-40. doi: 10.3233/JHD-150143.

The role of iron in gray matter degeneration in Huntington's disease: a magnetic resonance imaging study.

Sánchez-Castañeda C, Squitieri F, Di Paola M, Dayan M, Petrollini M, Sabatini U.

Hum Brain Mapp. 2015 Jan;36(1):50-66. doi: 10.1002/hbm.22612.

Micro RNA-214 contributes to proteasome independent downregulation of beta catenin in Huntington's disease knock-in striatal cell model STHdhQ111/Q111.

Ghatak S, Raha S.

Biochem Biophys Res Commun. 2015 Apr 10;459(3):509-14. doi: 10.1016/j.bbrc.2015.02.137.

Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.

Krause A, Mitchell C, Essop F, Tager S, Temlett J, Stevanin G, Ross C, Rudnicki D, Margolis R.

Am J Med Genet B Neuropsychiatr Genet. 2015 Oct;168(7):573-85. doi: 10.1002/ajmg.b.32332.

Abnormal Electrophysiological Motor Responses in Huntington's Disease: Evidence of Premanifest Compensation.

Turner LM, Croft RJ, Churchyard A, Looi JC, Apthorp D, Georgiou-Karistianis N.

PLoS One. 2015 Sep 25;10(9):e0138563. doi: 10.1371/journal.pone.0138563.

RAN Translation in Huntington Disease.

Bañez-Coronel M, Ayhan F, Tarabochia AD, Zu T, Perez BA, Tusi SK, Pletnikova O, Borchelt DR, Ross CA, Margolis RL, Yachnis AT, Troncoso JC, Ranum LP.

Neuron. 2015 Nov 18;88(4):667-77. doi: 10.1016/j.neuron.2015.10.038.

MicroRNA-124 slows down the progression of Huntington's disease by promoting neurogenesis in the striatum.

Liu T, Im W, Mook-Jung I, Kim M.

Neural Regen Res. 2015 May;10(5):786-91. doi: 10.4103/1673-5374.156978.

Chromosome substitution strain assessment of a Huntington's disease modifier locus.

Ramos EM, Kovalenko M, Guide JR, St Claire J, Gillis T, Mysore JS, Sequeiros J, Wheeler VC, Alonso I, MacDonald ME.

Mamm Genome. 2015 Apr;26(3-4):119-30. doi: 10.1007/s00335-014-9552-9.